Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

MDD: early-phase trial registry

3 of 8 indexed MDD trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count

MDD: 8 US clinical trials tracked, 3 recruiting.

MDD is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Texas at Austin, running 1 of these trials.

Enrollment posture brief

Registry condition mdd

OPEN 3 | RECR 38% | LATE 0 | EARLY 1 | RANK #2176 | SPON 1

Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)

Activity, Motor75%Achalasia50%MDD (this)38%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near MDD

MDD lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for MDD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. MDD is recruiting below its size-band peers.

    3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of MDD trials is spread across many organizations.

    University of Texas at Austin accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most MDD trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.

  4. MDD research is mostly interventional.

    8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on MDD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Traditional Behavioral Activation Behavioral
1 trials
Extended Reality-Enhanced Behavioral Activation Behavioral
1 trials
Basic health push app Behavioral
1 trials
Evolution Behavioral
1 trials
Problem Solving Therapy Other
1 trials
TMS treatment Device
1 trials
Transcranial Magnetic Stimulation Sham Procedure
1 trials
Transcranial Magnetic Stimulation Procedure
1 trials

US sites by state

Facility locations filed on MDD trials. A trial with sites in several states counts in each.

California 2 trials
Texas 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Missouri 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this MDD page

8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MDD condition card totals 8 registered trials; most-linked intervention Traditional Behavioral Activation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.